Black Rock Inc. Biotechnology

Black Rock Inc.

$4.35 Trillion
Q2 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
LEXX Lexaria Bioscience Corp.	$12.9M	$76,000 0.0% of portfolio	27,445	Q2 2024 Added 1,719.96%
EYEN Eyenovia, Inc.	$3.76M	$73,000 0.0% of portfolio	124,799	Q2 2024 Reduced 92.08%
HOOK Hookipa Pharma Inc.	$106M	$73,000 0.0% of portfolio	124,672	Q2 2024 Reduced 56.9%
DARE Dare Bioscience, Inc.	$265M	$69,000 0.0% of portfolio	203,632	Q2 2024 Reduced 48.59%
ICCC Immucell Corp	$40.4M	$66,000 0.0% of portfolio	13,764	Q2 2024 Reduced 7.34%
SPRB Spruce Biosciences, Inc.	$8.95M	$64,000 0.0% of portfolio	124,734	Q2 2024 Reduced 32.92%
ARMP Armata Pharmaceuticals, Inc.	$75.5M	$63,000 0.0% of portfolio	22,921	Q2 2024 Reduced 3.97%
XLO Xilio Therapeutics, Inc.	$30.2M	$63,000 0.0% of portfolio	66,418	Q2 2024 Added 46.44%
ACXP Acurx Pharmaceuticals, Inc.	$9.36M	$61,000 0.0% of portfolio	27,503	Q2 2024 Added 47.17%
MREO Mereo Biopharma Group PLC	$444M	$60,000 0.0% of portfolio	16,792	Q2 2024 Reduced 48.87%
INAB In8 Bio, Inc.	$8.33M	$48,000 0.0% of portfolio	57,080	Q2 2024 Added 102.38%
ORGS Orgenesis Inc.	$46M	$47,000 0.0% of portfolio	79,889	Q2 2024 Reduced 36.2%
PHVS Pharvaris N.V.	$601M	$42,000 0.0% of portfolio	2,268	Q3 2023 Added 1,353.85%
VINC Vincerx Pharma, Inc.	$4.24M	$38,000 0.0% of portfolio	47,080	Q1 2024 Reduced 26.73%
CLNN Clene Inc.	$330M	$30,000 0.0% of portfolio	83,451	Q2 2024 Reduced 53.64%
EPIX Essa Pharma Inc.	$76.7M	$29,000 0.0% of portfolio	5,609	Q1 2024 Reduced 26.94%
HCWB Hcw Biologics Inc.	$14M	$27,000 0.0% of portfolio	42,662	Q2 2024 Reduced 7.33%
EQ Equillium, Inc.	$24M	$26,000 0.0% of portfolio	38,317	Q2 2024 Added 905.43%
IMMX Immix Biopharma, Inc.	$30.5M	$26,000 0.0% of portfolio	13,455	Q2 2024 Reduced 30.36%
PMCB Pharma Cyte Biotech, Inc.	$32.8M	$26,000 0.0% of portfolio	13,346	Q2 2024 Reduced 36.76%
UNCY Unicycive Therapeutics, Inc.	$10.2M	$25,000 0.0% of portfolio	51,837	Q2 2024 New
IMAB I Mab	$87.3M	$12,000 0.0% of portfolio	7,684	Q2 2024 Reduced 3.02%
SNTI Senti Biosciences, Inc.	$172M	$11,000 0.0% of portfolio	40,052	Q4 2022 Added 1,424.05%
ANEB Anebulo Pharmaceuticals, Inc.	$37.4M	$10,000 0.0% of portfolio	3,761	Q2 2024 Reduced 7.11%
RNXT Renovo Rx, Inc.	$12M	$10,000 0.0% of portfolio	9,162	Q2 2024 Reduced 56.04%
GLTO Galecto, Inc.	$137M	$9,000 0.0% of portfolio	21,205	Q2 2024 Reduced 58.44%
BWV Blue Water Vaccines Inc.	$2.34M	$9,000 0.0% of portfolio	53,561	Q2 2023 Reduced 23.75%
BIVI Biovie Inc.	$64.9M	$8,000 0.0% of portfolio	21,172	Q2 2024 Reduced 93.54%
PRQR Pro Qr Therapeutics N.V.	$183M	$6,000 0.0% of portfolio	3,945	Q2 2023 Reduced 21.41%
CLLS Cellectis S.A.	$84.2M	$5,000 0.0% of portfolio	2,755	Q4 2022 Reduced 99.02%
NTRB Nutri Band Inc.	$34.2M	$5,000 0.0% of portfolio	1,048	Q2 2024 New
SNSE Sensei Biotherapeutics, Inc.	$16M	$4,000 0.0% of portfolio	7,777	Q2 2024 Reduced 76.84%
SLGL Sol Gel Technologies Ltd.	$24.3M	$2,000 0.0% of portfolio	3,089	Q3 2021 Reduced 11.59%
XCUR Exicure, Inc.	$46.9M	$1,000 0.0% of portfolio	5,113	Q1 2024 Reduced 0.23%
PRTG Portage Biotech Inc.	$74M	$1,000 0.0% of portfolio	8,203	Q2 2024 Reduced 73.77%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	4,084,339	Q2 2024 Added 53.65%
VIRI Virios Therapeutics, Inc.	$81.4M	$0 0.0% of portfolio	755	Q2 2023 Reduced 98.14%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.